Skip to main content
Shaperon Inc. logo

Shaperon Inc. — Investor Relations & Filings

Ticker · 378800 ISIN · KR7378800007 KO Manufacturing
Open in API
Filings indexed 146 across all filing types
Latest filing 2025-11-11 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 378800

About Shaperon Inc.

https://www.shaperon.com/

Shaperon Inc. is a clinical-stage biotechnology company that develops novel immune therapeutics for inflammatory diseases. The company's primary focus is on the development of innovative inflammasome inhibitors. Its core technology is based on a unique mechanism that modulates the GPCR19-P2X7 pathway to regulate the initiation and progression of inflammatory responses. This approach is applied to a pipeline of drug candidates targeting various inflammation-driven conditions.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시) (주주배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is titled '증권 발행결과(자율공시)' which translates to 'Securities Issuance Result (Voluntary Disclosure)'. It details the issuance of shares via a rights offering (주주배정 유상증자), including the number of shares issued, the amount raised, dates of board resolution and payment, and listing plans. It also references related disclosures about the rights offering and securities registration statements. The content is focused on the outcome of a capital increase through share issuance, which fits the category of announcements regarding new share issues or capital changes. The document length is short (1504 characters) and contains specific issuance details, not a full financial report. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA).
2025-11-11 Korean
증권발행실적보고서
Capital/Financing Update Classification · 95% confidence The document is titled '증권발행실적보고서' which translates to 'Securities Issuance Performance Report'. It details a capital increase through a rights offering and general public subscription, including issuance amounts, subscription schedules, allocation details, major shareholder changes before and after the capital increase, and the use of proceeds from the capital raise. The document includes detailed financial and operational plans related to the capital raised, such as clinical trial funding and new business investments. This content clearly relates to a capital raising event and changes in the company's capital structure. It is not an annual report, earnings release, or management discussion, nor is it a regulatory filing or announcement of a report. The document is comprehensive and substantive, not a brief announcement or certification. Therefore, the appropriate classification is 'Capital/Financing Update' (CAP).
2025-11-11 Korean
유상증자또는주식관련사채등의청약결과(자율공시) (주주배정)
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement of the subscription results for a rights offering (유상증자) or related bond issuance. It includes specifics such as the type of securities, subscription dates, subscription results, handling of fractional shares, and future schedule for refund and listing. It also references previous related announcements and filings. The content focuses on the outcome of a capital increase process rather than the capital increase decision itself or a full financial report. This fits the definition of a Capital/Financing Update (CAP), which covers updates on fundraising and capital structure changes. The document length is under 5,000 characters and contains substantive details about the subscription results, not just a brief notice or a link to a report, so it is not a Report Publication Announcement (RPA).
2025-11-05 Korean
유상증자최종발행가액확정 (주주배정후 실권주 일반공모)
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the final determination of the issuance price for a rights offering (유상증자 최종발행가액 확정). It details the number of shares, types, face value, and the calculation method for the issuance price. It references regulatory rules and provides links to related filings such as securities registration statements and previous price determinations. The content is focused on capital raising and pricing details, which aligns with updates on financing activities or capital structure changes. The document length is 3307 characters, which is relatively short but contains substantive information about the capital issuance price determination, not just a notice of report publication. Therefore, it fits best under Capital/Financing Update (CAP).
2025-10-30 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 95% confidence The document is a detailed disclosure related to a capital raising event, specifically a rights offering and general public offering of shares. It includes information about the securities being issued, the number of shares, the offering price, underwriting details, subscription periods, and the use of proceeds. The document also contains corrections to previously submitted offering documents and detailed calculations of the final offering price. The presence of terms like '투자설명서' (investment prospectus), '유상증자' (paid-in capital increase), and detailed underwriting and subscription information clearly indicate this is a capital/financing update. It is not an annual report, earnings release, or any other type of report but a disclosure about a capital raising event. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence score.
2025-10-30 Korean
[기재정정]주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 100% confidence The document is titled '주요사항보고서(유상증자결정)' which translates to 'Material Information Report (Decision on Paid-in Capital Increase)'. It details the correction of a previously submitted material report regarding a capital increase, including specifics on the issuance price, purpose of funds, subscription details, and allocation methods. The document is a regulatory announcement about a financing event (capital increase) rather than a full financial report or earnings release. It is not an annual or interim report, nor a call transcript or management report. The content focuses on capital raising activities and related disclosures, fitting the definition of a Capital/Financing Update. The document length is sufficient and contains substantive details about the capital increase decision, not merely an announcement of a report publication or a certification. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2025-10-30 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.